Deal
Trilegal | India | 10 Jan 2024
Trilegal advised JB Pharma on its acquisition of a portfolio of certain opthamalogy brands from Novartis. JB Pharmaceuticals Limited entered into a…
Bristows | United Kingdom | 29 Mar 2023
“Is it proper for the courts of England and Wales to make a declaration solely for the purpose of influencing a decision by a foreign court on an…
Osborne Clarke | United Kingdom | 15 Dec 2022
The Court of Appeal has upheld the decision of the High Court to reject Teva's application for Arrow declaratory relief for importing and selling…
Bird & Bird LLP | Belgium, European Union, Netherlands | 9 Dec 2022
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with the original trade mark of the reference…
McDermott Will & Emery | USA | 6 Oct 2022
In a rare action by the Supreme Court of the United States, Chief Justice Roberts granted Novartis’s emergency request for a stay of a mandate from…
De Berti Jacchia Franchini Forlani Studio Legale | European Union | 21 Jul 2022
In data 7 luglio 2022, la Corte di Giustizia dell’Unione Europea si è Pronunciata nella Causa C-261/21, F. Hoffmann-La Roche Ltd e a. Contro Autorità…
Kilpatrick Townsend & Stockton LLP | USA | 26 Jan 2022
The specification shall contain a written description of the invention. To meet the written description requirement, the applicant must convey with…
Lexology PRO | USA | 14 Apr 2021
A senior SEC enforcement official said it’s often a challenge for government lawyers to determine whether to impose a compliance monitor on a company.
Venable LLP | USA | 8 Mar 2021
Chief Judge Stark of the US District Court for the District of Delaware recently ruled in favour of Novartis Pharmaceuticals Corporation against the…
Lexology Learn videos PRO
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
Rafael Ferri, legal director at Novartis (Brazil), looks back at his experiments with gamification to boost compliance-business engagement while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.